report-image

Parenteral Nutrition Market Size - By Composition(Amino Acids, Fats, Carbohydrates, Trace Elements, Vitamins, Minerals), by Consumer(Children and Newborns, Adult), by End-use(Hospitals, Clinics, Homecare) & Region - Forecasts 2023 - 2033

  • PUBLISHED ON
  • 2024-09-27
  • NO OF PAGES
  • 256
  • CATEGORY
  • Healthcare & Life Sciences

Global Parenteral Nutrition Market Analysis by Composition, Consumer, End Use and Region and segments forecast till 2033

Market Overview

The global parenteral nutrition market was worth USD 6,400 million in 2022 and is anticipated to amplify at a CAGR of 6.0% over 2023-2033, thereby accumulating USD 10,700 million by end of the analysis timeline.

The major factors aiding the growth of this marketplace are rising geriatric population, high rate of pre-mature births worldwide, and favorable government initiatives to promote nutritional awareness. Also, increasing prevalence of chronic diseases and metabolic disorders, growing malnutrition across the world, and widespread adoption of home healthcare are positively swaying the market dynamics.

On the contrary, lesser clinical evidence to prove the efficacy of the novel technology and lack of awareness among the masses are likely to impede market progression in the ensuing years. There has been a steep rise in the prevalence of malnutrition particularly in developing and under-developed nation due to lack of food resources and economic disparity. This in turn has increased the demand for parenteral nutrition. Various government and private organizations are taking efforts to develop and provide effective treatment to malnourished individuals, thereby adding traction to the over market expansion.

Rising rate of pre-mature births is creating lucrative opportunities for the market sphere to prosper. Premature babies tend to suffer from underdeveloped immunity and low weight, putting them at a high mortality rate. Therefore, healthcare authorities are focusing on reducing early birth mortalities, thereby aiding market growth.

Report Scope

Report Attributes

Description

Market Size in 2022

USD 6,400 Million

Market Forecast in 2033

USD 10,700 Million

CAGR % 2023-2033

4.2%

Base Year

2022

Historic Data

2020-2021

Forecast Period

2023-2033

Report USP

Production, Consumption, company share, company heatmap, company production capacity, growth factors and more

Segments Covered

Composition, Consumer, and End Use

Regional Scope

North America, Europe, APAC, South America and Middle East and Africa

Country Scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria

Key Companies

Actavis Inc, Fresenius Kabi AG, Pfizer Inc, B. Braun Melsungen AG, Grifolis SA, Baxter International Inc, Otsuka Pharmaceutical Factory Inc, Sichuan Kelun Pharmaceutical Co., Ltd, Vifor Pharma Group, and Allergen, Inc., Amanta Healthcare, Anhui Medipharm Co., Ltd, Aculife Healthcare, Claris Lifesciences Limited, Servona GmbH, ICU Medical, Inc., SGD-Pharma, Groupe Danone, Nutricia North America, Mead Johnson Nutrition Company, Meiji Co., Ltd., Nestlé Health Science S.A and Others. 


Impact of COVID

The COVID-19 pandemic has had a significant impact on the Parenteral Nutrition Market, as it disrupted the global healthcare system and supply chains. The lockdowns and restrictions imposed to control the spread of the virus led to a decline in demand for parenteral nutrition products as elective surgeries were postponed and hospital admissions decreased. However, the demand for parenteral nutrition products has started to recover in recent months, driven by an increase in hospital admissions and surgeries. The COVID-19 vaccine rollout and easing of restrictions in some countries have also contributed to the recovery of the market. To aid in the recovery of the Parenteral Nutrition Market, manufacturers and suppliers have been implementing various strategies. These include increasing production capacity to meet the growing demand, ensuring the availability of raw materials and essential components, and implementing cost optimization strategies to maintain profitability.

Companies in the Parenteral Nutrition Market have also been focusing on developing innovative products and expanding their product portfolios to meet the evolving needs of patients and healthcare providers. They are also investing in research and development activities to identify new formulations and delivery systems that can improve patient outcomes and reduce the cost of treatment. Overall, the Parenteral Nutrition Market is expected to continue its recovery in the coming years, driven by an increase in healthcare spending, a growing aging population, and rising incidences of chronic diseases that require parenteral nutrition therapy.

 Composition Insights

The composition segment of the parenteral nutrition market refers to the various components used in the formulation of parenteral nutrition solutions. These solutions are primarily made up of carbohydrates, amino acids, lipids, electrolytes, and trace elements. Carbohydrates are the primary source of energy in parenteral nutrition solutions and are usually provided in the form of glucose monohydrate. Amino acids are the building blocks of proteins and are used to support tissue repair and growth. Lipids are a source of essential fatty acids and calories, and they help reduce the risk of liver dysfunction and cholestasis. Electrolytes, such as sodium, potassium, and calcium, are added to parenteral nutrition solutions to maintain electrolyte balance in the body. Trace elements, such as iron, zinc, and copper, are added to prevent micronutrient deficiencies.

Consumer Insights

As parenteral nutrition is administered through an IV or catheter, it is primarily used in hospital settings to treat patients who are unable to consume food orally or through a feeding tube. Therefore, the consumer segment for parenteral nutrition is limited and mainly consists of hospitals and other healthcare facilities. The demand for parenteral nutrition is driven by the number of patients requiring this treatment in hospitals, as well as the availability of healthcare facilities offering this service. However, there is also a growing trend towards home-based parenteral nutrition (HPN) for patients who require long-term PN therapy. This allows patients to receive treatment in the comfort of their own homes and can result in cost savings for healthcare providers. The demand for HPN is expected to increase in the future, driven by factors such as an aging population and the rising incidence of chronic diseases. This may lead to increased demand for parenteral nutrition products by individual consumers or their caregivers.

End Use Insights

The end-use segment of the parenteral nutrition market is mainly divided into hospitals, clinics, and home care settings. Hospitals and clinics are the major end-users of parenteral nutrition products. Hospitals have traditionally been the largest consumers of parenteral nutrition products due to their ability to provide intensive medical care to critically ill patients. Moreover, hospitals have better infrastructure and resources to manage the complex administration and monitoring requirements of parenteral nutrition. However, with the increasing popularity of home parenteral nutrition, the demand from home care settings is expected to witness significant growth in the coming years.

Regional Insights

In terms of geographical ambit, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa are the major benefactors to the growth of this business sphere. Among these, North America captured a market share of 41% in 2021 and is anticipated to showcase similar amplification trends over the forecast period. This is attributable to increasing research expenditure in healthcare sector, rising prevalence of chronic ailments, and favorable reimbursement policies & regulations in the region. Further, Asia Pacific is expected to register substantial CAGR over the stipulated timeline owing to rising chronic disease rate driven by unhealthy eating habits, escalating demand for cost effective treatment, population expansion and low cognizance about nutrition.

Competitive Analysis

Some of the major companies operating within Parenteral Nutrition Market are Actavis Inc, Fresenius Kabi AG, Pfizer Inc, B. Braun Melsungen AG, Grifolis SA, Baxter International Inc, Otsuka Pharmaceutical Factory Inc, Sichuan Kelun Pharmaceutical Co., Ltd, Vifor Pharma Group, and Allergen, Inc., Amanta Healthcare, Anhui Medipharm Co., Ltd, Aculife Healthcare, Claris Lifesciences Limited, Servona GmbH, ICU Medical, Inc., SGD-Pharma, Groupe Danone, Nutricia North America, Mead Johnson Nutrition Company, Meiji Co., Ltd., Nestlé Health Science S.A and Others.

Recent News

·         In June 2021, Baxter International Inc. announced the launch of its new parenteral nutrition formulation, Clinimix E 5/10 in Europe. This product is designed to provide safe and efficient nutrition to patients who are unable to eat or digest food properly.

·         In March 2021, B. Braun Melsungen AG announced the acquisition of Lauer Membran Wassertechnik GmbH, a company specializing in water treatment systems. This acquisition is expected to help B. Braun expand its portfolio of parenteral nutrition products.

·         In February 2021, Sichuan Kelun Pharmaceutical Co. Ltd. announced plans to invest approximately USD 53 million to build a new parenteral nutrition production facility in China. The facility is expected to have an annual production capacity of 1,000 tons.

·         In January 2021, Fresenius Kabi AG announced the launch of its new parenteral nutrition product, Kabiven Peripheral. This product is designed to provide complete and balanced nutrition to critically ill patients who require parenteral nutrition support.

·         In November 2020, Aculife Healthcare Private Limited announced the launch of its new parenteral nutrition product, Nutriflex Omega Plus, in India. This product is designed to provide essential fatty acids to patients who require parenteral nutrition support.

1. Global Parenteral Nutrition Market Introduction and Market Overview

1.1. Objective of the Market Research Study

1.2. Parenteral Nutrition Market Definition & Description

1.3. Research Data Parameters & Reporting Timelines

1.3.1. Historical Data Reporting Years – 2020 to 2021

1.3.2. Projected Data Reporting Years – 2022 to 2033

1.3.3. Reporting Data Parameters – Value (US$ Million)

1.4. Global Parenteral Nutrition Market Scope and Market Estimation

1.4.1. Global Parenteral Nutrition Overall Market Size (US$ Million), Market CAGR (%), Market Estimates & Forecast (2020 to 2033)

1.4.2. Global Parenteral Nutrition Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2020 to 2033

1.5. Parenteral Nutrition Market Segmentation

1.5.1. Composition of Global Parenteral Nutrition Market

1.5.2. Consumer of Global Parenteral Nutrition Market

1.5.3. End-use of Global Parenteral Nutrition Market

1.5.4. Key Regions of Parenteral Nutrition Market

 

2. Global Parenteral Nutrition Market - Executive Summary

2.1. Global Parenteral Nutrition Market – Summary & Snapshot

2.2. Global Parenteral Nutrition Market, By Composition (US$ Million)

2.3. Global Parenteral Nutrition Market, By Consumer (US$ Million)

2.4. Global Parenteral Nutrition Market, By End-use (US$ Million)

2.5. Global Parenteral Nutrition Market, By Geography (US$ Million)

2.6. Global Parenteral Nutrition Market Outlook & Future Opportunities

 

3. Parenteral Nutrition Market Trends, Outlook, and Factors Analysis

3.1. Global Parenteral Nutrition Market Industry Development Trends under COVID-19 Outbreak

3.1.1. Global COVID-19 Status Overview

3.1.2. Influence of COVID-19 Outbreak on Global Parenteral Nutrition Market Industry Development

3.1.3. Pre & Post COVID-19 Trends and Scenarios

3.2. Parenteral Nutrition Market Dynamics (Growth Impacting Factors & Rationales)

3.2.1. Drivers

3.2.1.1. The growing burden of various chronic diseases such as diabetes, cancer, and other conditions has led in deficiency in vital and essential nutrients in parents and adults and has created a demand for parenteral nutrition.

3.2.2. Restraints

3.2.2.1. Inappropriate or unsupervised or self-suggested usage of parenteral nutrition can further maximize the risk of patients.

3.2.3. Opportunities

3.2.3.1. Government initiatives made for use and acceptance of parenteral nutrition.

3.2.4. Impact Analysis of Drivers and Restraints

3.3. Ecosystem/ Value Chain Analysis

3.4. Porter’s Five Forces Analysis

3.5. SWOT Analysis

3.6. PEST Analysis

3.7. Average Selling Prices and Pricing Trends Analysis of Parenteral Nutrition Market

3.8. Technological Roadmap

3.9. Key Investment Pockets of Parenteral Nutrition Market

3.9.1. By Composition

3.9.2. By Consumer

3.9.3. By End-use

3.9.4. By Applications

3.9.5. By Regions

 

4. Global Parenteral Nutrition Market: Estimates & Historic Trend Analysis (2020 to 2021)

4.1. Global Parenteral Nutrition Market, 2020 – 2021 (US$ Million)

4.2. Global Parenteral Nutrition Market, By Composition, 2020 To 2021 (US$ Million)

4.3. Global Parenteral Nutrition Market, By Consumer, 2020 To 2021 (US$ Million)

4.4. Global Parenteral Nutrition Market, By End-use, 2020 To 2021 (US$ Million)

4.5. Global Parenteral Nutrition Market, By Region, 2020 To 2021 (US$ Million)

 

5. Global Parenteral Nutrition Market Estimates & Forecast Trend Analysis, by Composition

5.1. Global Parenteral Nutrition Market Share (%) Estimates and Forecasts, by Composition, 2022 & 2033

5.2. Global Parenteral Nutrition Market Revenue (US$ Million) Estimates and Forecasts, by Composition, 2022 to 2033

5.2.1. Amino Acids

5.2.2. Fats

5.2.3. Carbohydrates

5.2.4. Trace Elements

5.2.5. Vitamins

5.2.6. Minerals

5.2.7. Others

 

6. Global Parenteral Nutrition Market Estimates & Forecast Trend Analysis, by Consumer

6.1. Global Parenteral Nutrition Market Share (%) Estimates and Forecasts, By Consumer, 2022 & 2033

6.2. Global Parenteral Nutrition Market Revenue (US$ Million) Estimates and Forecasts, by Consumer, 2022 to 2033

6.2.1. Children and Newborns

6.2.2. Adult

 

7. Global Parenteral Nutrition Market Estimates & Forecast Trend Analysis, by End-use

7.1. Global Parenteral Nutrition Market Share (%) Estimates and Forecasts, By End-use, 2022 & 2033

7.2. Global Parenteral Nutrition Market Revenue (US$ Million) Estimates and Forecasts, by End-use, 2022 to 2033

7.2.1. Hospitals

7.2.2. Clinics

7.2.3. Homecare

7.2.4. Others

 

8. Global Parenteral Nutrition Market Analysis and Forecast, by Region

8.1. Global Parenteral Nutrition Market Share (%) Estimates and Forecasts, By Region, 2022 & 2033

8.2. Global Parenteral Nutrition Market Revenue (US$ Million) Estimates and Forecasts, By Region, 2022 To 2033

8.2.1. North America

8.2.2. Europe

8.2.3. Asia Pacific

8.2.4. Middle East and Africa

8.2.5. Latin America

 

9. North America Parenteral Nutrition Market: Estimates & Forecast Trend Analysis

9.1. North America Parenteral Nutrition Market Assessments & Key Findings

9.2. North America Parenteral Nutrition Market Share (%) Estimates and Forecasts, 2022 & 2033

9.3. North America Parenteral Nutrition Market Size Estimates and Forecast (US$ Million) (2022 To 2033)

9.3.1. By Composition

9.3.2. By Consumer

9.3.3. By End-use

9.3.4. By Major Country

9.3.4.1. The U.S.

9.3.4.2. Canada

 

10. Europe Parenteral Nutrition Market: Estimates & Forecast Trend Analysis

10.1. Europe Parenteral Nutrition Market Assessments & Key Findings

10.2. Europe Parenteral Nutrition Market Share (%) Estimates and Forecasts, 2022 & 2033

10.3. Europe Parenteral Nutrition Market Size Estimates and Forecast (US$ Million) (2022 to 2033)

10.3.1. By Composition

10.3.2. By Consumer

10.3.3. By End-use

10.3.4. By Major Country

10.3.4.1. Germany

10.3.4.2. The U.K.

10.3.4.3. France

10.3.4.4. Italy

10.3.4.5. Spain

10.3.4.6. Rest of Europe (includes all other European countries)

 

11. Asia Pacific Parenteral Nutrition Market: Estimates & Forecast Trend Analysis

11.1. Asia Pacific Parenteral Nutrition Market Assessments & Key Findings

11.2. Asia Pacific Parenteral Nutrition Market Share (%) Estimates and Forecasts, 2022 & 2033

11.3. Asia Pacific Parenteral Nutrition Market Size Estimates and Forecast (US$ Million) (2022 To 2033)

11.3.1. By Composition

11.3.2. By Consumer

11.3.3. By End-use

11.3.4. By Major Country

11.3.4.1. China

11.3.4.2. Japan

11.3.4.3. India

11.3.4.4. ASEAN

11.3.4.5. South Korea

11.3.4.6. Rest of Asia Pacific (includes all other Asia Pacific countries)

 

12. Middle East & Africa Parenteral Nutrition Market: Estimates & Forecast Trend Analysis

12.1. Middle East & Africa Parenteral Nutrition Market Assessments & Key Findings

12.2. Middle East & Africa Parenteral Nutrition Market Share (%) Estimates and Forecasts, 2022 & 2033

12.3. Middle East & Africa Parenteral Nutrition Market Size Estimates and Forecast (US$ Million) (2022 To 2033)

12.3.1. By Composition

12.3.2. By Consumer

12.3.3. By End-use

12.3.4. By Major Country

12.3.4.1. GCC

12.3.4.2. South Africa

12.3.4.3. Egypt

12.3.4.4. Rest of Middle East & Africa (includes all other Middle East & Africa countries)

 

13. Latin America Parenteral Nutrition Market: Estimates & Forecast Trend Analysis

13.1. Latin America Market Assessments & Key Findings

13.2. Latin America Parenteral Nutrition Market Share (%) Estimates and Forecasts, 2022 & 2033

13.3. Latin America Parenteral Nutrition Market Size Estimates and Forecast (US$ Million) (2022 to 2033)

13.3.1. By Composition

13.3.2. By Consumer

13.3.3. By End-use

13.3.4. By Major Country

13.3.4.1. Brazil

13.3.4.2. Mexico

13.3.4.3. Rest of Latin America (includes all other Latin America countries)

 

14. Competitive Landscape

14.1. Parenteral Nutrition Market Revenue Share Analysis (%), By Major Players (2021)

14.2. Parenteral Nutrition Market Competition Matrix, By Leading Players

14.3. Parenteral Nutrition List of Emerging, Prominent and Leading Players

14.4. Major Mergers & Acquisitions, Partnership, Joint Venture, Expansions, Deals, Recent Developments, Etc.

 

15. Company Profiles

15.1. Baxter

15.1.1. Company Overview & Insights

15.1.2. Financial Performance

15.1.3. Product / Service Portfolio

15.1.4. Geographical Footprint & Share

15.1.5. Strategic Initiatives & Key Developments

*Similar details would be provided for all the players mentioned below

15.2. Baxter

15.3. Allergan

15.4. Actavis Inc

15.5. Otsuka Pharmaceutical Factory, Inc

15.6. Grifols, S.A.

15.7. B. Braun Melsungen AG

15.8. Vifor Pharma

15.9. Fresenius Kabi AG

15.10. Sichuan Kelun Pharmaceutical Co., Ltd.

15.11. Pfizer Inc

15.12. Amanta Healthcare

15.13. Anhui Medipharm Co., Ltd

15.14. Aculife Healthcare

15.15. Claris Lifesciences Limited

15.16. Servona GmbH

15.17. ICU Medical, Inc.,

15.18. SGD-Pharma

15.19. Groupe Danone

15.20. Nutricia North America

15.21. Mead Johnson Nutrition Company

15.22. Meiji Co., Ltd.

15.23. Nestlé Health Science S.A

15.24. Others

 

16. Assumptions and Research Methodology

16.1. Data Mining

16.2. Secondary Research

16.3. Primary Research

16.4. Subject Matter Expert Advice

16.5. Quality Check

16.6. Final Review

16.7. Data Triangulation

16.8. Bottom-Up Approach

16.9. Top Down Approach

16.10. Research Flow

16.11. Key Insights from Industry Experts

16.12. Data Compositions

16.13. Assumptions

16.14. Limitations

 

17. Conclusions and Recommendations

17.1. Key Research Findings and Conclusion

17.2. Key Insights & Recommendations from Analysts

Quality Assurance Process

  1. We Market Research’s Quality Assurance program strives to deliver superior value to our clients.

We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.

Market Research Process




We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.

To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
  • Project kickoff meeting with client
  • Conduct frequent client communications
  • Form project steering committee
  • Assign a senior SR executive as QA Executive
  • Conduct internal editorial & quality reviews of project deliverables
  • Certify project staff in SR methodologies & standards
  • Monitor client satisfaction
  • Monitor realized value post-project

Case Study- Automotive Sector

One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).

Solution

The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research

The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.

Market Estimates and Forecast

In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.

Case Study- ICT Sector

Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.


Business Solution

An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.


Conclusion

The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.

CHOOSE LICENSE TYPE
QLOUD
Pricing

Select a license type that suits your business needs

Single User Access

US $3499

Only Three Thousand Four Hundred Ninety Nine US dollar

  • 1 User access
  • 15% Additional Free Customization
  • Free Unlimited post-sale support
  • 100% Service Guarantee until achievement of ROI
Multi User Cost

US $4499

Only Four Thousand Four Hundred Ninety Nine US dollar

  • 5 Users access
  • 25% Additional Free Customization
  • Access Report summaries for Free
  • Guaranteed service
  • Dedicated Account Manager
  • Discount of 20% on next purchase
  • Get personalized market brief from Lead Author
  • Printing of Report permitted
  • Discount of 20% on next purchase
  • 100% Service Guarantee until achievement of ROI
Enterprise User Cost

US $5499

Only Five Thousand Four Hundred Ninety Nine US dollar

  • Unlimited User Access
  • 30% Additional Free Customization
  • Exclusive Previews to latest or upcoming reports
  • Discount of 30% on next purchase
  • 100% Service Guarantee until achievement of ROI